Microspike technology

Spike Architectonics Public Company Limited

Pathum Thani, Thailand

1. Company Overview Spike Architectonics Co., Ltd., a deep-tech healthcare startup emerging from Thailand s National Science and Technology Development Agency (NSTDA), is dedicated to transforming the future of drug and active-ingredient delivery through its flagship innovation: MicroSpike™ , a breakthrough microneedle-based transdermal delivery platform. Founded with a mission to solve one of the most persistent challenges in pharmaceuticals and cosmetics— inefficient skin penetration —the company unites world-class research from the National Nanotechnology Center (NANOTEC) with robust commercial execution to deliver innovations ready for medical, cosmetic, and wellness applications. Spike Architectonics stands at the intersection of materials science, biomedical engineering, and industrial innovation. The company has demonstrated extraordinary momentum since commercialization, earning over 225% revenue growth in 2024 , supplying hospitals nationwide, exporting advanced cosmetic ingredients to Japan, France, and Singapore, and receiving recognition through national innovation awards including the CP All 7 Innovation Awards (1st Prize) and the Outstanding Technologist of Thailand Award 2024 . Beyond product launches, Spike Architectonics aims to become the global backbone technology provider for next-generation drug, cosmetic, and medical delivery systems—embodied in the long-term vision known as “MicroSpike™ Inside.” 2. The Problem: Limitations of Traditional Transdermal Delivery Human skin is one of the most formidable biological barriers. While designed to protect us from pathogens and toxins, the outermost layer— the stratum corneum —also blocks most pharmaceutical and cosmetic molecules from entering the deeper skin layers where therapeutic action is needed. Even the world s most advanced formulations face limitations: Minimal penetration efficiency Large molecules cannot pass through the skin naturally Topicals lose up to 90% of their efficacy on the skin surface Needle-based delivery is painful, invasive, and costly High infection risk and user discomfort contribute to low compliance Hair regrowth procedures , in particular, involve painful injections, high cost per session, and limited results, especially for those with severe hair loss (as described in the Re-Hair Growth technology comparison). These long-standing barriers have hindered the full potential of active compounds in medicine, dermatology, and cosmeceuticals. The global market has been waiting for a platform that is effective, painless, safe, universal, and ready for wide deployment . 3. The Breakthrough Solution: MicroSpike™ MicroSpike™ is a next-generation transdermal delivery platform engineered to open microscopic channels through the stratum corneum— without needles, without dissolving polymers, and without pain. Unlike conventional microneedles, MicroSpike™ technology is: ● Non-dissolving It does not leave residue under the skin, enabling higher biocompatibility and reduced risk. ● Non-invasive and painless Users feel little to no discomfort. ● Ultra-thin, flexible, transparent Resembles a sheet mask, but with precise microstructures for delivery. ● Universal and compatible with almost any active compound Works with drugs, serums, botanical extracts, biological molecules, and more. ● Produces ~100X increase in total flux area This means dramatically improved absorption and deeper penetration. ● Scientifically validated Supported by peer-reviewed research including DOI: 10.21203/rs.3.rs-750691/v1 . The technology s simplicity and universality make it a true platform , enabling developers, brands, hospitals, and innovators to integrate MicroSpike™ directly into their product pipelines. 4. How MicroSpike™ Works MicroSpike™ consists of micron-scale solid spikes arranged on an ultra-thin, flexible patch. When applied to the skin: Micro-channels are created within seconds through gentle pressure. These openings bypass the stratum corneum without reaching nerves or blood vessels. Active compounds —applied before or after patch placement—flow through these channels freely. The channels remain temporarily open long enough to ensure high-efficiency absorption . The skin restores itself naturally after removal. This allows a previously impossible combination: Deep delivery. No pain. No dissolution. No injection. No medical staff required. Because MicroSpike™ does not rely on dissolving materials or drug-loaded needles, it transforms into a universal plug-and-play delivery enhancer for endless product categories. 5. Product Portfolio Spike Architectonics currently offers a range of technologies and commercial products, including: A. Medical Applications N-JOINT Patch: For knee joint pain, utilized in leading hospitals such as Phyathai and Paolo. MicroSpike™ Re-Hair Growth Patch: Enhances scalp penetration for hair regrowth actives, solving pain points of injections and poor absorption. B. Cosmetic Wellness Applications MicroSpike™ cosmetic sheets for use with: Anti-aging serums Whitening and brightening actives Botanical extracts Hair growth tonics Acne care formulas Anti-inflammatory compounds C. Platform Licensing and OEM/ODM Spike Architectonics provides: Technology integration for global brands OEM/ODM manufacturing for medical and cosmetic companies Co-development of next-generation products Ingredient export for cosmetic formulation (currently exported to Japan, France, Singapore) 6. Technology Advantage vs Traditional Methods Traditional drug/cosmetic delivery Low penetration Painful injections Risk of irritation or infection High cost Ineffective on patients with severe symptoms (e.g., advanced hair loss) MicroSpike™ delivery No pain, no needles Immediate channel creation 100X flux area vs baseline Compatible with nearly all active compounds Easy and safe for consumer use No need for formulation redesign Preserves ingredient potency Biocompatible and residue-free MicroSpike™ upgrades traditional formulations into high-performance delivery systems , unlocking results previously achievable only through clinical procedures. 7. Market Opportunity Microneedle-based technologies represent one of the fastest-growing categories in the global medical and cosmetic industries. Market data from your slides confirms a strong upward trajectory: Global CAGR: 14.36% Asia Pacific CAGR: 17% Thailand CAGR: 16% Specific market segments unlocked by MicroSpike™ include: A. Medical Pain Management Knee osteoarthritis: $6.9 billion market B. Facial Skincare Sheet masks: $20.6 billion market globally C. Hair Regrowth A rapidly expanding market with unmet needs, due to painful, expensive injection-based protocols and limited efficacy. MicroSpike™ offers a non-invasive alternative positioned for fast adoption. D. Cosmetics, Wellness, and Dermatology Anti-aging Whitening Acne care Regenerative skincare Tattoo/skin barrier penetration enhancement Men s and women s personal care E. B2B Opportunities MicroSpike™ s universal nature makes it ideal for B2B commercialization: Cosmetic brands seeking differentiation Medical device companies adding new delivery systems Hospitals adopting non-invasive care solutions Wellness clinics upgrading procedures Pharmaceutical companies exploring transdermal pathways 8. Business Model Spike Architectonics operates as a B2B technology platform enabling multiple scalable revenue streams: OEM/ODM Manufacturing Developing custom products for brands, hospitals, and clinics. Integrated Technology Licensing Embedding MicroSpike™ inside partner product lines. Co-development Partnerships Joint innovation with medical and cosmetic leaders. Export of MicroSpike™ Ingredients Supplying raw materials and sheets for international markets. The diversified model ensures long-term financial stability, scalability, and global reach. 9. Scientific Foundation and IP Protection MicroSpike™ is supported by more than 37 patents across core microfabrication, biomedical application, device structure, and manufacturing methods. Key pillars protecting the technology: ● Proprietary microfabrication technique Enables highly precise and transparent microstructures. ● Non-dissolving microstructure innovation Unique compared to dissolvable microneedles widely used today. ● High-clarity polymer system Ensures optical transparency and biocompatibility. ● Structural stability Enables use with a wide range of compounds without degradation. ● Integration patents for medical and cosmetic formulations Moreover, the research was pioneered by NANOTEC, one of Asia s leading nanotechnology institutes, and successfully commercialized by Spike Architectonics—strengthening credibility and protecting the innovation s competitive edge. 10. Traction, Achievements Partnerships Spike Architectonics has achieved remarkable validation in a short period: ● 3 medical products already commercialized Including the N-Joint Patch and Re-Hair Growth Patch. ● Distribution in leading hospitals Phyathai Hospital Paolo Hospital Other major hospitals across Thailand ● International exports To Japan, France, Singapore for cosmetic innovation. ● Awards Recognition 1st Prize – CPALL 7 Innovation Awards Outstanding Technologist Award 2024 37 Patents protecting the ecosystem ● Research-to-Commercialization Partnership R D by NANOTEC Commercialization by Spike Architectonics This strong traction demonstrates that MicroSpike™ is not just theoretical technology—it is a commercially validated platform used daily in the real world . 11. Manufacturing Ecosystem and Quality Spike Architectonics is building a robust, internationally compliant production ecosystem. Manufacturing centers adhere to stringent medical-grade practices, including: Controlled environment microstructure fabrication Precision quality control using optical and mechanical analysis Scale-ready polymer molding and microfabrication lines Compliance roadmap for Thai FDA , ISO 13485 , and international medical standards (Aligned with company s roadmap and BOD plans.) 12. Roadmap and Vision: “MicroSpike™ Inside” Spike Architectonics is not merely a product company—it is positioning itself as a platform enabler for global industries. 2025 — Domestic Expansion Strengthen partnerships with Thai hospitals, clinics, and cosmetic brands Scale manufacturing capacity Launch new B2B collaborations 2026 — Global Readiness Technology accreditation and regulatory expansion Strategic co-development with international partners Preparation for overseas production and licensing 2027 — Becoming a Global Platform The MicroSpike™ Inside strategy envisions: MicroSpike™ integrated into global product lines Serving as a hidden backbone of leading cosmetic and medical brands Becoming the “Intel Inside” of transdermal delivery technologies The long-term direction is clear: MicroSpike™ will be the foundational delivery technology behind next-generation global healthcare and beauty products. 13. Impact on Healthcare and Society MicroSpike™ has the potential to redefine healthcare by: ● Eliminating pain from transdermal drug delivery No injections, no clinics, no trained personnel needed. ● Increasing treatment accessibility Lower-cost solutions for chronic pain, dermatological conditions, and hair loss. ● Reducing infection risk No skin-breaking needles; channels close naturally. ● Enabling at-home medical care Especially for elderly, mobility-limited, or rural populations. ● Supporting Thailand s national innovation goals By reducing reliance on imported medical technologies and strengthening local manufacturing. 14. Why MicroSpike™ Is a Global-Scale Innovation MicroSpike™ addresses the biggest unmet needs in drug delivery and cosmetic penetration: Painless and non-invasive Mass-producible Flexible for B2B integration Supported by deep IP and awards Scientifically validated Versatile across dozens of markets Already in hospitals and export markets Most importantly, MicroSpike™ is not a single product —it is a modular technology platform with the power to revolutionize multiple industries simultaneously. Where dissolving microneedles and topical formulations fall short, MicroSpike™ emerges as the practical, scalable, and universal solution . 15. Summary Spike Architectonics is creating a future where: Medical patches relieve joint pain without injections Cosmetic products show dramatically enhanced results Hair regrowth becomes comfortable and affordable Hospitals adopt non-invasive treatment protocols Global brands integrate MicroSpike™ into their flagship lines Thailand becomes a world leader in nanotechnology-based drug delivery platforms MicroSpike™ is more than technology. It is a vision for accessible, painless, and effective care for everyone. Backed by strong science, commercial traction, global export capabilities, and a clear roadmap, Spike Architectonics stands ready to scale its innovation to the world stage and redefine the global standard for transdermal delivery.